Lipocalin 2 expression is associated with aggressive features of endometrial cancer

BACKGROUND: Increased expression of lipocalin 2 (LCN2) has been observed in several cancers. The aim of the present study was to investigate LCN2 in endometrial cancer in relation to clinico-pathologic phenotype, angiogenesis, markers of epithelial-mesenchymal transition (EMT), and patient survival....

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Mannelqvist, Monica, Stefansson, Ingunn M, Wik, Elisabeth, Kusonmano, Kanthida, Raeder, Maria B, Øyan, Anne M, Kalland, Karl-Henning, Moses, Marsha A, Salvesen, Helga B, Akslen, Lars A
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2012
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3493289/
https://ncbi.nlm.nih.gov/pubmed/22559235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-12-169
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky